PSI is a non-profit organisation formed in 1977 which provides a forum for regular discussion of statistics and issues relating to the practice of statistics in the pharmaceutical industry, as well as promoting good statistical practice within the industry.

Why join PSI

We provide...

opportunities for our members to network, develop themselves and shape the industry

We are...

run by our membership through a network of committees and special interest groups

We promote...

best statistical practice to our members and promote the value of statistics to the external world

Statisticians in the Pharmaceutical Industry
Executive Office: Durford Mill, Petersfield, Hampshire, GU31 5AZ e: t: +44 (0)1730 715 235 

Latest News

Show all news

EventsFuture Events

  • PSI One Day Meeting: Sample Size Re-estimation – dealing with those known unknowns! - Dates: 02 – 02 Nov, 2016

    The aim of this PSI one day meeting is to present an overview of available methods for sample size re-estimation together with several case studies where such methods have been used in late phase clinical trials.
  • Introduction to Simulation - Dates: 08 – 09 Nov, 2016

    The aim of this course is to provide participants an understanding simulation techniques. The 2 day course includes a variety of practical examples and example code will be provided in both SAS and R. Presented by Les Huson
  • PSI Scientific Committee Webinar: Rare Diseases: Regulatory and Study Design Considerations - Dates: 16 – 16 Nov, 2016

    Registration is free to attend! Talks from John Scott (Deputy Director of the Division of Biostatistics in the FDA's Center for Biologics Evaluation and Research) and Lisa Hampson (Lecturer in Statistics at Lancaster University)
  • Design of Experiments in Medicine - Dates: 23 – 23 Nov, 2016

    Design of Experiments in Medicine Birkbeck College, London Wednesday 23rd November, 1:00-4:40 pm International Biometric Society (British & Irish Region)
  • Health Technology Assessment (HTA) Training Course - Dates: 26 – 27 Jan, 2017

    Presented by Mark Sculpher, Neil Hawkins and members of the HTA SIG
  • Dose Finding in Drug Development using MCP-Mod - Dates: 01 – 02 Mar, 2017

    This course will introduce and discuss methods for Phase II dose finding studies, including a review of basic multiple comparisons and modelling methods, as traditionally used in these studies. A unified strategy for designing and analysing dose finding trials denoted MCP-Mod, combining multiple comparisons and modelling, will be the focus of the course.
  • Introduction To Industry Training Course 2017 - Dates: 01 Oct, 2017 – 31 Jul, 2018

    AIM: To describe the drug development process from research right through to research, toxicology, data management & role of the CRO, clinical trials, product development & manufacture and marketing.